Home > Healthcare > Medical Devices > Women Health Devices Market

Women Health Devices Market - By Type (Devices, Consumables), By Product (Surgical, Diagnostics, Contraceptives, Labor & Delivery, Critical Care), By Application (Cancer, Osteoporosis, Uterine Fibroids, Pregnancy), By End-use & Forecast, 2021-2027

  • Report ID: GMI3191
  • Published Date: Dec 2021
  • Report Format: PDF

Women Health Devices Market Size

Women Health Devices Market size valued at over USD 26 billion in 2020 and is projected to grow at a CAGR of more than 6.9% between 2021 and 2027. The market growth is attributed to the increasing awareness regarding women wellness along with improving women care in remote areas. Women health has been a growing area of concern and the government is taking up various initiatives to increase awareness regarding women hygiene and wellness in rural areas.
 

Women Health Devices Market Overview

Increasing burden of chronic and infectious diseases in females is poised to boost the market expansion. Increased consumption of unhealthy food and change in lifestyle will raise the risk of disease. Moreover, lack of awareness regarding genital health and sanitation along with unavailability of well-developed healthcare facilities in underdeveloped countries will drive the industry growth during the forecast period.
 

The global pandemic has affected millions of people worldwide, resulting into high mortality. The pandemic has negatively impacted the market due to limited visits to the healthcare settings. Furthermore, owing to strict regulations related to non-emergency medical procedures and high infection rate, there was decline in hospital visits and scheduled procedures globally during COVID-19 pandemic. However, with growing disease burden and resuming of healthcare services with decline in COVID-19 cases, the market will witness substantial growth in the coming years.
 

Women Health Devices Market Analysis

Devices segment in the women health devices market is expected to showcase 6.7% growth rate through 2027. Increasing patient preference for technologically advanced treatment procedures coupled with upsurge of minimally invasive techniques has propelled demand for devices for several surgical procedures. Additionally, rising prevalence of chronic and infectious diseases among women would increase demand for better diagnosis and treatment options, thus contributing to the segment growth.
 

Contraceptives segment is estimated to attain a CAGR of 6.9% till 2027 led by the rising prevalence of sexually transmitted diseases among women. According to the WHO, every year around 374 million new infections occur, with one of four being sexually transmitted infections. In addition, growing inclination of population towards planned pregnancy increases demand for contraceptive implants, intrauterine devices (IUD) and systems this will fuel the segment expansion during the forecast period.
 

Osteoporosis segment captured more than USD 1 billion in 2020 impelled by the increasing prevalence of osteoporosis majorly among elderly population. Furthermore, osteoporosis is more common among females due to weaker bones. According to National Osteoporosis Foundation, around 10 million Americans have osteoporosis.
 

Ambulatory surgical centers held 14% of the market share in 2020. Various advantages associated with ambulatory surgical centers such as minimized risk of hospital-acquired infections (HAIs), shorter patient stay, cost-effective treatment and quality care will foster the segment demand. Additionally, accessibility to advanced technologies will further augment the segment value.
 

North America Women Health Devices Market
 

North America women health devices market accounted for over 32% of revenue share in 2020 owing to high awareness and adoption of women health devices including implants and self-diagnostic tests. Additionally, growing demand for technologically advanced solutions will accelerate the regional size. Moreover, government focus on maintaining women health & wellness, and presence of strong foothold of prominent industry leaders in the region will further stimulate the North America market progression over the coming years.
 

Women Health Devices Market Share

The global market consists of several players including:

  • Hologi
  • Caldera Medical
  • Carestream Health
  • Cardinal Health
  • CooperSurgical
  • FHoffmann-La Roche
  • GE Healthcare

These companies are adopting several expansion and growth strategies such as partnerships, acquisitions and product launches to increase their market presence.
 

The women health devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Click here to Buy Section of this Report


Market, By Type

  • Devices
  • Consumables

Market, By Product

  • Surgical
  • Diagnostics
  • Contraceptives
  • Labor & Delivery
  • Critical Care
  • Others

Market, By Application

  • Cancer
  • Osteoporosis
  • Infectious Disease
  • Uterine Fibroids
  • Post-menopausal Syndrome
  • Pregnancy
  • Female Sterilization
  • Others

Market, By End-use

  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Denmark
    • Sweden
    • Czech Republic
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Qatar

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size of women health devices surpassed USD 26 billion in 2020 and will expand at a CAGR of over 6.9% from 2021 to 2027 driven by the surging awareness regarding women wellness and improving women care in remote areas.

The devices are anticipated to depict a growth rate of 6.7% up to 2027 owing to rising patient preference for technologically advanced treatment procedures and the upsurge of minimally invasive techniques.

The contraceptives will grow at a CAGR of 6.9% through 2027 considering the increasing prevalence of sexually transmitted diseases among women.

North America market recorded 32% of revenue share in 2020 and will grow with mounting awareness and adoption of numerous devices such as self-diagnostic tests and implants.

Major companies across the industry include F. Hoffman-La Roche, Caldera Medical, GE Healthcare, Carestream Health, CooperSurgical, Cardinal Health, and others.

Women Health Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2020
  • Companies covered: 13
  • Tables & Figures: 298
  • Countries covered: 23
  • Pages: 200
 Download PDF